Skip to main navigation Skip to search Skip to main content

Corrigendum to “Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 Inhibits prostate cancer stem cell-induced tumor growth” (Cancer Letters, (2017), 406, C, (71-80), (S0304383517304810), 10.1016/j.canlet.2017.08.004)

  • Gulzar Ahmad
  • , Rana El Sadda
  • , Galina Botchkina
  • , Iwao Ojima
  • , James Egan
  • , Mansoor Amiji
  • Northeastern University
  • Stony Brook University
  • Inc.

Research output: Contribution to journalComment/debate

Abstract

After the publication of this article, it was brought to the authors’ attention that in Fig. 1A (Characterization of DHA-SBT-1214 nanoemulsion formulation.), The transmission electron micrograph (TEM) of the placebo (NE-Placebo) and DHA-SBT-1214 nanoemulsion formulation (NE-DHA-SBT-1214) images were identical. After comparing with the original TEM data, the authors found those two images belong to DHA-SBT-1214 nanoemulsion. The corrected image for the transmission electron micrograph (TEM) of the placebo (NE-Placebo) and DHA-SBT-1214 nanoemulsion formulation (NE-DHA-SBT-1214) are shown as below. The analysis, results and conclusions of the manuscript remain valid. The authors apologize for this error.(Figure presented).

Original languageEnglish
Article number218043
JournalCancer Letters
Volume633
DOIs
StatePublished - Nov 28 2025

Fingerprint

Dive into the research topics of 'Corrigendum to “Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 Inhibits prostate cancer stem cell-induced tumor growth” (Cancer Letters, (2017), 406, C, (71-80), (S0304383517304810), 10.1016/j.canlet.2017.08.004)'. Together they form a unique fingerprint.

Cite this